MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$270,923K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Available For Sale
Share-based compensation
Proceeds from exercise of the co...
Others
Negative Cash Flow Breakdown
Purchases
Taxes paid related to net settle...
Change in fair value of investme...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-290,606
355,744
-313,701
-166,039
Share-based compensation
83,342
77,169
104,997
81,821
Change in fair value of investments
36,637
-25,922
21,592
128,501
Change in fair value of debt and liability instruments
0
0
-24,416
-20,959
Gain on sale of subsidiary interests
-
0
0
-
Gain on deconsolidation of subsidiaries
-
11,027
-
-
Gain on sale of telavant net assets
-
0
0
0
Impairment loss on operating lease right-of-use assets
-
0
15,594
-
Accretion of discount and amortization of premium on available-for-sale marketable securities, net
5,691
22,992
-
-
Accretion of discount and amortization of premium on marketable securities, net
-
-
8,723
9,822
Accretion of discount and amortization of premium on held-to-maturity marketable securities, net
0
13,520
-
-
Realized gain from sales of marketable securities
-
629
347
-
Loss on extinguishment of debt
-
0
0
-
Depreciation and amortization
600
638
691
921
Non-cash lease expense
1,394
1,864
2,527
1,942
Other
-9,789
5,516
9,718
-5,980
Other current assets
23,836
-18,454
2,733
4,390
Other assets
-1,868
7,416
-
-
Litigation settlement receivable
1,392
770,235
-
-
Accounts payable
7,109
16,155
-3,988
2,996
Accrued expenses
-13,911
63,226
8,580
12,520
Operating lease liabilities
-286
-275
-786
-846
Accrued interest
-
0
-
-
Income tax payable
-10,177
85,045
-
-
Other
-
-
-8,299
3,205
Other liabilities
7,930
-1,008
-
-
Net cash used in operating activities
-270,504
-163,818
-196,484
-185,664
Purchases
286,510
4,795,855
-
-
Available For Sale
568,189
1,122,300
-
-
Proceeds from sales
-
821,367
-
-
Held To Maturity Securities
-
0
-
-
Held To Maturity
0
2,185,000
-
-
Purchases of marketable securities
-
-
1,013,713
976,730
Proceeds from sale of telavant net assets, net
-
0
0
-
Proceeds from maturities of marketable securities
-
-
2,745,000
-
Proceeds from sale of subsidiary interests
-
0
0
0
Maturities of marketable securities
-
-
-
1,105,000
Proceeds from sales of marketable securities
-
-
200,766
-
Cash decrease upon deconsolidation of subsidiaries
-
4,418
0
-
Purchase of property and equipment
419
1,261
-4,935
7,848
Other
-
0
2,518
-
Net cash provided by (used in) investing activities
281,260
173,491
109,470
120,422
Repurchase of the companys common shares-Parent Company
-
318,103
-
-
Repurchase of the companys common shares-Subsidiaries
-
1,400
-
-
Proceeds from issuance of the companys common shares, net of issuance costs paid
-
0
-
-
Proceeds from issuance of subsidiary common shares, net of issuance costs paid
-
0
193,605
-
Repayment of debt by subsidiary
-
0
0
0
Payments on principal portion of finance lease obligations
-
0
0
0
Contribution from minority interest holder to subsidiary
-
0
39,250
-
Repurchase of the companys common shares
-1,564
-
0
0
Payment of subsidiary dividend
-
0
-
-
Proceeds from exercise of the companys and subsidiary stock options
76,019
51,185
118,814
68,294
Proceeds from exercise of the companys warrants
-
0
-
-
Taxes paid related to net settlement of equity awards
51,435
8,752
23,856
6,481
Payment for redemptions of the companys warrants
-
0
-
-
Proceeds from issuance of the companys common shares under employee stock purchase plan
635
0
381
774
Net cash used in financing activities
-181,510
-68,777
328,194
62,587
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
315
1,316
430
1,206
Net change in cash, cash equivalents and restricted cash
-170,439
-57,788
241,610
-1,449
Cash, cash equivalents and restricted cash at beginning of period
1,430,982
1,248,609
1,248,609
1,248,609
Cash, cash equivalents and restricted cash at end of period
1,260,543
1,430,982
1,488,770
1,247,160
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Available For Sale
$568,189K
Net cash provided by
(used in) investing...
$281,260K
(125.91%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
$315K
(-61.35%↓ Y/Y)
Canceled cashflow
$286,929K
Net change in cash,
cash equivalents and...
-$170,439K
(88.46%↑ Y/Y)
Canceled cashflow
$281,575K
Share-based compensation
$83,342K
(1.42%↑ Y/Y)
Other
-$9,789K
(11.67%↑ Y/Y)
Other liabilities
$7,930K
Accounts payable
$7,109K
(160.53%↑ Y/Y)
Other assets
-$1,868K
Non-cash lease expense
$1,394K
(-28.26%↓ Y/Y)
Depreciation and
amortization
$600K
(-45.36%↓ Y/Y)
Proceeds from exercise of
the companys and...
$76,019K
(152.92%↑ Y/Y)
Repurchase of the companys
common shares
-$1,564K
(-100.75%↓ Y/Y)
Proceeds from issuance of
the companys common...
$635K
Purchases
$286,510K
Purchase of property and
equipment
$419K
(-89.62%↓ Y/Y)
Net cash used in
operating activities
-$270,504K
(-32.35%↓ Y/Y)
Canceled cashflow
$112,032K
Net cash used in
financing activities
-$181,510K
(3.33%↑ Y/Y)
Canceled cashflow
$78,218K
Net loss
-$290,606K
(-6.10%↓ Y/Y)
Change in fair value of
investments
$36,637K
(291.57%↑ Y/Y)
Other current assets
$23,836K
(18721.88%↑ Y/Y)
Accrued expenses
-$13,911K
(44.36%↑ Y/Y)
Income tax payable
-$10,177K
Accretion of discount and
amortization of premium on...
$5,691K
Litigation settlement
receivable
$1,392K
Operating lease
liabilities
-$286K
(40.17%↑ Y/Y)
something is missing
-$208,293K
Taxes paid related to
net settlement of...
$51,435K
(439.60%↑ Y/Y)
Buy us a coffee
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)
ROIV_BIG copy-svg
Roivant Sciences Ltd. (ROIV)